• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC LAUNCHER UNK GUIDE CATHETER CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC LAUNCHER UNK GUIDE CATHETER CATHETER, PERCUTANEOUS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Hematoma (1884); Hemorrhage/Bleeding (1888)
Event Date 05/01/2003
Event Type  Injury  
Manufacturer Narrative
Journal article: safety, feasibility and efficacy of transradial primary angioplasty in patients with acute myocardial infarction year: 2003 ref: www. Federcardio. It/pdf/2003/05/20030117. Pdf age or date of birth: average age. Sex: majority gender. Date: of event: date of publication. Death was reported as a clinical outcome of this study, however there is no information to suggest the device has caused or contributed to a death. If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article titled - safety, feasibility and efficacy of transradial primary angioplasty in patients with acute myocardial infarction - was submitted for review. This article aimed to investigate the safety, feasibility and efficacy of transradial primary percutaneous coronary intervention (pci) in patients with acute myocardial infarction (ami). Adverse clinical events (including death, ventricular arrhythmias, reinfarction, recurrent angina, target lesion revascularization and heart failure) were evaluated during the in-hospital follow-up. A total of 726 patients were enrolled in the study. Of these 163 procedures were performed via the right transradial approach (group a) and 563 were done via the transfemoral approach (group b) for comparison. A medtronic 6fr launcher guide catheter was amongst the devices used during the procedures. Right radial access was achieved in all patients in group a, except 2 who were switched to a right femoral approach and 7 switched to a left radial approach because no adequate guiding position could be obtained from the right radial artery. This was attributed to the tortuosity of the brachycephalic artery. No procedure performed through the radial artery was associated with inadequate support of the guiding catheter. Severe hemorrhagic complications occurred in a number of patients. Two of these patients developed a hemorrhagic stroke at 10 and 14 hours after coronary angioplasty. Two others developed cardiac tamponade and the other three had large hematomas at the puncture site. These complications necessitated a longer length of hospitalization and two of these patients required transfusion. Access site bleeding occurred in eleven patients. In hospital death occurred in eleven patients. Two patients presented with post-infarction angina. Five presented with life-threatening ventricular arrhythmias. The incidence of major bleeding complications after the use of 6f guiding catheters by the femoral approach was deemed to be low.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameLAUNCHER UNK GUIDE CATHETER
Type of DeviceCATHETER, PERCUTANEOUS
Manufacturer (Section D)
MEDTRONIC, INC
37a cherry hill dr
danvers MA 01923
MDR Report Key12719825
MDR Text Key281658894
Report Number1220452-2021-00069
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
PMA/PMN Number
K132673
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial
Report Date 10/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/29/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Was Device Available for Evaluation? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received10/15/2021
Is This a Reprocessed and Reused Single-Use Device? No

Patient Treatment Data
Date Received: 10/29/2021 Patient Sequence Number: 1
-
-